Search results

cost per quality-adjusted life year (QALY) gained (the NICE economic model developed for this guideline could easily be...

Result type

Research recommendation

Published

4 May 2017

Evidence-based recommendations on trastuzumab emtansine (Kadcyla) for human epidermal growth factor receptor 2 (HER2)-positive, unresectable, locally advanced or metastatic breast cancer in adults who have had trastuzumab and a taxane.

Result type

Technology appraisal guidance

Last updated

20 November 2017

Evidence-based recommendations on laparoscopic gastric plication for the treatment of morbid obesity. This involves folding the stomach in on itself and stitching it together to reduce its volume.

Result type

Interventional procedures guidance

Published

27 November 2012

Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis. This involves using ultrasound waves and a drug to break up the clot.

Result type

Interventional procedures guidance

Published

26 June 2015

Evidence-based recommendations on tenofovir disoproxil for treating chronic hepatitis B.

Result type

Technology appraisal guidance

Published

22 July 2009

Accessing NHS care and treatment recommended by NICE

NICE has developed a medtech innovation briefing (MIB) on NaviCam for diagnosing gastrointestinal tract conditions .

Result type

Medtech innovation briefing

Published

11 May 2017

Agency for Care Effectiveness, International Advisory Group. (remunerated to NICE) Share options in Legal and General Plc. (remunerated)...

Agency for Care Effectiveness, International Advisory Group. (remunerated to NICE) Share options in Legal and General Plc. (remunerated)...

Agency for Care Effectiveness, International Advisory Group. (remunerated to NICE) Share options in Legal and General Plc. (remunerated)...

NICE has developed a medtech innovation briefing (MIB) on Arctic Sun 5000 for therapeutic hypothermia after cardiac arrest .

Result type

Medtech innovation briefing

Published

18 July 2017

Evidence-based recommendations on certolizumab pegol (Cimzia) for treating moderate to severe plaque psoriasis in adults.

Result type

Technology appraisal guidance

Published

17 April 2019

NICE has developed a medtech innovation briefing (MIB) on HemaClear for bloodless surgical field during limb surgery .

Result type

Medtech innovation briefing

Published

15 July 2019

Evidence-based recommendations on certolizumab pegol (Cimzia) and secukinumab (Cosentyx) for treating active psoriatic arthritis in adults.

Result type

Technology appraisal guidance

Published

24 May 2017

NICE has developed a medtech innovation briefing (MIB) on AmnioSense for unexplained vaginal wetness in pregnancy .

Result type

Medtech innovation briefing

Published

26 November 2019